Cargando…

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy

Dendritic cells (DCs) are specialized antigen-presenting cells that have a notable role in the initiation and regulation of innate and adaptive immune responses. In the context of cancer, appropriately activated DCs can induce anti-tumor immunity by activating innate immune cells and tumor-specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Youra, Clements, Derek R., Sterea, Andra M., Jang, Hyun Woo, Gujar, Shashi A., Lee, Patrick W. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690876/ https://www.ncbi.nlm.nih.gov/pubmed/26690204 http://dx.doi.org/10.3390/v7122953

Ejemplares similares

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
por: Holay, Namit, et al.
Publicado: (2017)

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
por: Gujar, Shashi A, et al.
Publicado: (2014)

Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages
por: Clements, Derek R., et al.
Publicado: (2017)

Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities
por: Kim, Youra, et al.
Publicado: (2021)

Oncolytic Virus-Mediated Reversal of Impaired Tumor Antigen Presentation
por: Gujar, Shashi A., et al.
Publicado: (2014)

TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway
por: Almasi, Shekoufeh, et al.
Publicado: (2019)

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy
por: Kumar, Vishnupriyan, et al.
Publicado: (2021)

Reovirus in cancer therapy: an evidence-based review
por: Clements, Derek, et al.
Publicado: (2014)

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
por: Gujar, Shashi, et al.
Publicado: (2018)

Repurposing CD8(+) T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
por: Gujar, Shashi, et al.
Publicado: (2020)

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
por: Warford, Jordan R., et al.
Publicado: (2018)

After virus exposure, early bystander naïve CD8 T cell activation relies on NAD(+) salvage metabolism
por: Holay, Namit, et al.
Publicado: (2023)

Prospect of Plasmacytoid Dendritic Cells in Enhancing Anti-Tumor Immunity of Oncolytic Herpes Viruses
por: Schuster, Philipp, et al.
Publicado: (2019)

Oncolytic viruses in cancer therapy
por: Vähä-Koskela, Markus J.V., et al.
Publicado: (2007)

Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy?
por: Prestwich, Robin J, et al.
Publicado: (2008)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
por: Yoo, So Young, et al.
Publicado: (2017)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases
por: Vorobyev, P. O., et al.
Publicado: (2022)

Lessons from the Endoplasmic Reticulum Ca(2+) Transporters—A Cancer Connection
por: Zhai, Xingjian, et al.
Publicado: (2020)

Anti-cancer oncolytic activity of respiratory syncytial virus
por: Echchgadda, I, et al.
Publicado: (2009)

Harnessing Oncolytic Virus-Mediated Anti-Tumor Immunity
por: Schirrmacher, Volker, et al.
Publicado: (2014)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)

Trial watch: Oncolytic viruses for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch:: Oncolytic viruses for cancer therapy
por: Pol, Jonathan, et al.
Publicado: (2014)

The gamble between oncolytic virus therapy and IFN
por: Li, Qingbo, et al.
Publicado: (2022)

Choindroitinase ABC I-Mediated Enhancement of Oncolytic Virus Spread and Anti Tumor Efficacy: A Mathematical Model
por: Kim, Yangjin, et al.
Publicado: (2014)

Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets
por: Alard, Emilie, et al.
Publicado: (2020)

Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
por: Pipperger, Lisa, et al.
Publicado: (2021)

Pharmacological Modulation of Anti-Tumor Immunity Induced by Oncolytic Viruses
por: Forbes, Nicole E., et al.
Publicado: (2014)

Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
por: Tilgase, Andra, et al.
Publicado: (2020)

Oncolytic virus immunotherapy: future prospects for oncology
por: Raja, Junaid, et al.
Publicado: (2018)

Oncolytic viruses: finally delivering
por: Seymour, Leonard W, et al.
Publicado: (2016)

Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
por: Svensson-Arvelund, Judit, et al.
Publicado: (2022)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Pierce, Kyle M., et al.
Publicado: (2021)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

Oncolytic viruses in melanoma
por: Robinson, Camille, et al.
Publicado: (2022)

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
por: Loskog, Angelica
Publicado: (2015)

Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_00e0goksli28g92tcp1m82l497